Logo image of GBLB.BR

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Stock Fundamental Analysis

EBR:GBLB - Euronext Brussels - BE0003797140 - Common Stock - Currency: EUR

71.6  +0.1 (+0.14%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GBLB. GBLB was compared to 47 industry peers in the Financial Services industry. Both the profitability and the financial health of GBLB get a neutral evaluation. Nothing too spectacular is happening here. GBLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year GBLB was profitable.
GBLB had a positive operating cash flow in the past year.
Of the past 5 years GBLB 4 years were profitable.
In the past 5 years GBLB always reported a positive cash flow from operatings.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

GBLB has a worse Return On Assets (0.37%) than 70.21% of its industry peers.
With a Return On Equity value of 0.73%, GBLB is not doing good in the industry: 68.09% of the companies in the same industry are doing better.
GBLB has a Return On Invested Capital (1.80%) which is in line with its industry peers.
GBLB had an Average Return On Invested Capital over the past 3 years of 0.81%. This is significantly below the industry average of 10.10%.
The last Return On Invested Capital (1.80%) for GBLB is above the 3 year average (0.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.37%
ROE 0.73%
ROIC 1.8%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

GBLB has a Profit Margin of 1.03%. This is in the lower half of the industry: GBLB underperforms 63.83% of its industry peers.
In the last couple of years the Profit Margin of GBLB has declined.
GBLB's Operating Margin of 7.50% is in line compared to the rest of the industry. GBLB outperforms 40.43% of its industry peers.
GBLB's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 66.90%, GBLB is doing good in the industry, outperforming 65.96% of the companies in the same industry.
In the last couple of years the Gross Margin of GBLB has remained more or less at the same level.
Industry RankSector Rank
OM 7.5%
PM (TTM) 1.03%
GM 66.9%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBLB is destroying value.
GBLB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for GBLB has been reduced compared to 5 years ago.
The debt/assets ratio for GBLB is higher compared to a year ago.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

GBLB has an Altman-Z score of 1.45. This is a bad value and indicates that GBLB is not financially healthy and even has some risk of bankruptcy.
GBLB has a Altman-Z score (1.45) which is comparable to the rest of the industry.
GBLB has a debt to FCF ratio of 10.80. This is a negative value and a sign of low solvency as GBLB would need 10.80 years to pay back of all of its debts.
GBLB has a Debt to FCF ratio (10.80) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.48 indicates that GBLB is not too dependend on debt financing.
The Debt to Equity ratio of GBLB (0.48) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 10.8
Altman-Z 1.45
ROIC/WACC0.3
WACC6%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GBLB has a Current Ratio of 1.95. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
GBLB's Current ratio of 1.95 is fine compared to the rest of the industry. GBLB outperforms 74.47% of its industry peers.
GBLB has a Quick Ratio of 1.58. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GBLB (1.58) is better than 74.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.58
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

The earnings per share for GBLB have decreased strongly by -96.80% in the last year.
GBLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.51% yearly.
Looking at the last year, GBLB shows a decrease in Revenue. The Revenue has decreased by -1.35% in the last year.
GBLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.51% yearly.
EPS 1Y (TTM)-96.8%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-112.25%
Revenue 1Y (TTM)-1.35%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-3.51%

3.2 Future

The Earnings Per Share is expected to decrease by -14.59% on average over the next years. This is quite bad
Based on estimates for the next years, GBLB will show a decrease in Revenue. The Revenue will decrease by 0.00% on average per year.
EPS Next Y-21.19%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y0%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 105.29, the valuation of GBLB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of GBLB indicates a slightly more expensive valuation: GBLB is more expensive than 74.47% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of GBLB to the average of the S&P500 Index (28.87), we can say GBLB is valued expensively.
GBLB is valuated rather expensively with a Price/Forward Earnings ratio of 20.41.
GBLB's Price/Forward Earnings is on the same level as the industry average.
GBLB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 105.29
Fwd PE 20.41
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBLB indicates a somewhat cheap valuation: GBLB is cheaper than 61.70% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBLB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 13.27
EV/EBITDA 9.41
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

GBLB's earnings are expected to decrease with -14.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.93%, GBLB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.96, GBLB pays a better dividend. On top of this GBLB pays more dividend than 80.85% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, GBLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years0
Div Non Decr Years3
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

346.34% of the earnings are spent on dividend by GBLB. This is not a sustainable payout ratio.
GBLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP346.34%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
GBLB.BR Dividend Payout.GBLB.BR Dividend Payout, showing the Payout Ratio.GBLB.BR Dividend Payout.PayoutRetained Earnings

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (4/28/2025, 7:00:00 PM)

71.6

+0.1 (+0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-02 2025-05-02
Inst Owners26.32%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.91B
Analysts83.08
Price Target89.86 (25.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP346.34%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.96%
PT rev (3m)-1.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)8.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)23.54%
Valuation
Industry RankSector Rank
PE 105.29
Fwd PE 20.41
P/S 0.99
P/FCF 13.27
P/OCF 7.46
P/B 0.7
P/tB 1.38
EV/EBITDA 9.41
EPS(TTM)0.68
EY0.95%
EPS(NY)3.51
Fwd EY4.9%
FCF(TTM)5.4
FCFY7.54%
OCF(TTM)9.6
OCFY13.41%
SpS71.98
BVpS102.05
TBVpS51.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 0.73%
ROCE 3.05%
ROIC 1.8%
ROICexc 2.1%
ROICexgc 3.14%
OM 7.5%
PM (TTM) 1.03%
GM 66.9%
FCFM 7.5%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
ROICexc(3y)0.92%
ROICexc(5y)1.25%
ROICexgc(3y)1.32%
ROICexgc(5y)1.66%
ROCE(3y)1.37%
ROCE(5y)1.91%
ROICexcg growth 3Y-6.63%
ROICexcg growth 5Y-8.4%
ROICexc growth 3Y-11.16%
ROICexc growth 5Y-11.6%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 10.8
Debt/EBITDA 5.21
Cap/Depr 104.41%
Cap/Sales 5.84%
Interest Coverage 2.06
Cash Conversion 101.89%
Profit Quality 728.78%
Current Ratio 1.95
Quick Ratio 1.58
Altman-Z 1.45
F-Score8
WACC6%
ROIC/WACC0.3
Cap/Depr(3y)97.68%
Cap/Depr(5y)87.97%
Cap/Sales(3y)10%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.8%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-112.25%
EPS Next Y-21.19%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.35%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-3.51%
Revenue Next Year0%
Revenue Next 2Y0%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.37%
EBIT growth 3Y-19.25%
EBIT growth 5Y-15.81%
EBIT Next Year40.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.4%
FCF growth 3Y8.34%
FCF growth 5Y2.47%
OCF growth 1Y18.45%
OCF growth 3Y8.48%
OCF growth 5Y4.55%